Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IBBL Triples Number Biological Samples in 2013

Published: Sunday, June 01, 2014
Last Updated: Monday, June 23, 2014
Bookmark and Share
IBBL's 2013 annual report shows that the progress of the biobank is aided by a clever combination of national and international partnerships.

In 2013, IBBL (Integrated Biobank of Luxembourg) managed to substantially increase the number of samples in its collection by attacking from 2 angles: on a national level the biobank has launched 2 new cancer studies while increasing recruitment on existing studies, and on an international level IBBL has signed and executed new service contracts for large clinical trials and research consortia. 

Reaching beyond the borders has been a strategy that paid off. After signing a contract with the Breast International Group (BIG) and the European Organisation for the Research and Treatment of Cancer (EORTC) the previous year, in spring 2013, IBBL received a shipment of over 50,000 samples from a large clinical trial, developed and coordinated by these two organisations. The blood and tissue samples collected from breast cancer patients in 111 European institutions will be stored centrally in IBBL’s freezers for up to 20 years. In 2013, IBBL began working on another multi-national project with the EU Joint Programme for Neurodegenerative Disease (JPND). In addition to providing sample collection kits to multiple hospitals all over Europe, IBBL has developed a web-based “virtual biobank”, where all sample-related data is managed and easily accessible to consortium members.

In total, IBBL has signed 8 new service contracts for sample collection, processing or storage in 2013 with both new and returning clients. These service contracts contributed substantially to the increase in the number of biological samples from 67,000 in 2012 to 195,000 in 2013.

International endorsement
IBBL’s visibility has been further increased beyond Luxembourg and even beyond Europe through two programmes endorsed by the International Society for Biological and Environmental Repositories (ISBER). 90 laboratories from 24 countries participated in IBBL’s 2013 Proficiency Testing programme, which enables biobanks to assess the quality of their processing and testing methods. Similarly, the Principles of Biobanking continuing education course is also endorsed by ISBER and attracted students and professionals from multiple countries, like Egypt and Australia to Luxembourg. Run by IBBL and the University of Luxembourg, the 3 week course provides both theoretical and practical sessions to cover all aspects of running a high quality biobank.

Two new oncology studies to improve quality of life
At the same time as investing in international partnerships, IBBL remains active in Luxembourg as part of the Personalised Medicine Consortium (PMC). In addition to their existing research projects on lung and colon cancer, diabetes and Parkinson’s disease, IBBL and its PMC partners launched two new studies in 2013. With the support of Luxembourg’s urologists, the first study aims to facilitate prostate cancer diagnosis and reduce the need for multiple prostate biopsies. The second new study is led by Dr Stefan Rauh, oncologist at the Centre Hospitalier Emile Mayrisch, and is co-funded by IBBL and the Fondation Cancer. The goal of this second study is to evaluate whether an interactive assessment device can improve the management of chemotherapy side-effects and reduce hospitalisation. This project in particular illustrates how IBBL and the PMC strive to improve patients’ quality of life by personalising not only diagnosis and treatment but also patient care.

Standing out
To grow its partner and client base, IBBL has not just focused on the quality of its samples and services but also on its distinctiveness. As Dr Catherine Larue, CEO of IBBL, puts it, “a key focus of 2013 has been the investment in areas that make IBBL stand out from other biobanks, such as biospecimen and microbiome research”. As one of very few biobanks, IBBL carries out internal research on the best ways to collect, process or store biospecimens. The results of these research projects can then directly be applied to IBBL’s laboratory procedures to ensure samples are of the highest quality. In addition, these collaborative efforts with both industry and academic partners have led to multiple publications in scientific journals.

Finally, IBBL has set out to become the leading biobank for microbiome research, an area that has been gaining traction as several diseases have been linked to the microflora in our gut. In this respect, the biobank has spent a lot of effort on the development and validation of automated stool processing methods, as these samples are extensively used in gut microbiome research. Moreover, IBBL was chosen to organise the next International Human Microbiome Congress in spring 2015, which is expected to draw up to 1,000 experts from all over the world to Luxembourg.

An electronic version of the annual report is available for download using the link below.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Starving Stem Cells May Enable Scientists To Build Better Blood Vessels
Researchers from the University of Illinois at Chicago College of Medicine have uncovered how changes in metabolism of human embryonic stem cells help coax them to mature into specific cell types — and may improve their function in engineered organs or tissues.
Long-Term Culturing of Adult Stem Cells
A new procedure developed by Harvard Stem Cell Institute researchers (HSCI) at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells.
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Reclaiming The Immune System's Assault On Tumors
EPFL study shows a way to reclaim corrupted immune cells.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Body’s Own Gene Editing System Generates Leukemia Stem Cells
Inhibiting the editing enzyme may provide a new therapeutic approach for blood cancers.
Cirrhosis-Causing Cells Converted to Healthy Liver Cells in Mice
New approach that repairs liver from within may be more efficient than cell transplants.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!